Suppr超能文献

HIV-1受体与细胞嗜性。

HIV-1 receptors and cell tropism.

作者信息

Clapham P R, McKnight A

机构信息

Center for AIDS Research, Program in Molecular Medicine, Department of Molecular Genetics and Microbiology, University of Massachusetts Medical School, Worcester, Massachusetts 01605, USA.

出版信息

Br Med Bull. 2001;58:43-59. doi: 10.1093/bmb/58.1.43.

Abstract

HIV virus particles interact with several receptors on cell surfaces. Two receptors, CD4 and a co-receptor act sequentially to trigger fusion of viral and cellular membranes and confer virus entry into cells. For HIV-1, the chemokine receptor CCR5 is the predominant co-receptor exploited for transmission and replication in vivo. Variants that switch to use CXCR4 and perhaps other co-receptors evolve in some infected individuals and have altered tropism and pathogenic properties. Other cell surface receptors including mannose binding protein on macrophages and DC-SIGN on dendritic cells also interact with gp120 on virus particles but do not actively promote fusion and virus entry. These receptors may tether virus particles to cells enabling interactions with suboptimal concentrations of CD4 and/or co-receptors. Alternatively such receptors may transport cell surface trapped virions into lymph nodes before transmitting them to susceptible cells. Therapeutic strategies that prevent HIV from interacting with receptors are currently being developed. This review describes how the interaction and use of different cellular receptors influences HIV tropism and pathogenesis in vivo.

摘要

HIV病毒颗粒与细胞表面的多种受体相互作用。两种受体,即CD4和一种共受体,依次发挥作用,触发病毒膜与细胞膜的融合,并使病毒进入细胞。对于HIV-1而言,趋化因子受体CCR5是其在体内传播和复制过程中主要利用的共受体。在一些受感染个体中,会出现转而使用CXCR4以及可能其他共受体的变体,这些变体具有改变的嗜性和致病特性。其他细胞表面受体,包括巨噬细胞上的甘露糖结合蛋白和树突状细胞上的DC-SIGN,也会与病毒颗粒上的gp120相互作用,但不会积极促进融合和病毒进入。这些受体可能将病毒颗粒束缚在细胞上,从而使病毒能够与次优浓度的CD4和/或共受体相互作用。或者,此类受体可能会在将细胞表面捕获的病毒粒子传递给易感细胞之前,将其转运至淋巴结。目前正在研发阻止HIV与受体相互作用的治疗策略。本综述描述了不同细胞受体的相互作用及利用方式如何影响HIV在体内的嗜性和发病机制。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验